The role of the secretory immune response in the infection by Entamoeba histolytica

Parasite Immunology

Volumn 29, Issue 7, 2007, Pages 331-338

  Carrero, J C ^a   Cervantes Rebolledo, C ^a   Aguilar Diaz H ^a   Diaz Gallardo M Y ^b   Laclette, J P ^a   Morales Montor, J ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

Amoebiasis; Intestinal immunity; Secretory IgA; Vaccination

Indexed keywords

CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; CYCLOPHILIN; CYSTEINE DERIVATIVE; ELONGATION FACTOR; ENOLASE; ENTEROTOXIN; FREUND ADJUVANT; GALAPTIN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN A; METRONIDAZOLE; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; PEROXIREDOXINE; POLIOMYELITIS VACCINE; PROTOZOAL VACCINE; PROTOZOON ANTIBODY; RECOMBINANT ANTIBODY; RECOMBINANT LECA; RECOMBINANT VACCINE; RIBOSOME PROTEIN; SECRETORY IMMUNOGLOBULIN; SERINE DERIVATIVE; UNCLASSIFIED DRUG;

AMEBIASIS; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; BILE; BREAST MILK; CELL ADHESION; DYSENTERY; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; EPITHELIUM CELL; FECES; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INTESTINE INFECTION; INTESTINE MUCOSA; LIVER ABSCESS; MUCOSAL IMMUNITY; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; REVIEW; SALIVA; TROPHOZOITE; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; CHILD; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; MICE; MICE, INBRED C3H;

ENTAMOEBA HISTOLYTICA; MUS; PROTOZOA;

EID: 34250646694     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2007.00955.x     Document Type: Review

References (57)

1. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986 8 : 228 238.
2. Espinosa-Cantellano M Martínez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev 2000 13 : 318 331.
3. Woof JM Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006 208 : 270 282.
4. Ackers JP Mirelman D. Progress in research on Entamoeba histolytica pathogenesis. Curr Opin Microbiol 2006 9 : 367 373.
5. Olivos-García A, Nequiz-Avendaño M, Tello E et al. Inflammation, complement, ischemia and amoebic survival in acute experimental amoebic liver abscesses in hamsters. Exp Mol Pathol 2004 77 : 66 71.
6. Hughes MA Petri WA Jr. Amebic liver abscess. Infect Dis Clin North Am 2000 14 : 565 582.
7. Walsh JA. Epidemiology. In : Ravdin JI (eds) : Amebiasis. Human Infection by Entamoeba histolytica. New York, Edinburg, London, Melbourne, Churchill Livingstone, 1988 : 91 126.
8. Kelsall BL, Jackson TG, Gathiram V et al. Secretory immunoglobulin A antibodies to the galactose-inhibitable adherence protein in the saliva of patients with amebic liver disease. Am J Trop Med Hyg 1994 51 : 454 459.
9. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 2003 293 : 3 15.
10. Hanson LA Korotkova M. The role of breastfeeding in prevention of neonatal infection. Semin Neonatol 2002 7 : 275 281.
11. Morrow AL Rangel JM. Human milk protection against infectious diarrhea: implications for prevention and clinical care. Semin Pediatr Infect Dis 2004 15 : 221 228.
12. Holmgren J. Mucosal immunity and vaccination. FEMS Microbiol Immunol 1991 4 : 1 9.
13. Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA Bernier RH. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis 1991 163 : 1 6.
14. Vidarsson G, van der Pol WL, van den Elsen JM et al. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J Immunol 2001 166 : 6250 6256.
15. Lee CJ, Lee LH Gu XX. Mucosal immunity induced by pneumococcal glycoconjugate. Crit Rev Microbiol 2005 31 : 137 144.
16. Byrd W, de Lorimier A, Zheng ZR Cassels FJ. Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens. Adv Drug Deliv Rev 2005 57 : 1362 1380.
17. Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR van de Winkel JG. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect Immun 2001 69 : 4846 4850.
18. Ma JK, Hikmat BY, Wycoff K et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 1998 4 : 601 606.
19. Roach TI, Else KJ, Wakelin D, McLaren DJ Grencis RK. Trichuris muris: antigen recognition and transfer of immunity in mice by IgA monoclonal antibodies. Parasite Immunol 1991 13 : 1 12.
20. Inaba T, Sato H Kamiya H. Impeded establishment of the infective stage of Trichinella in the intestinal mucosa of mice by passive transfer of an IgA monoclonal antibody. J Vet Med Sci 2003 65 : 1227 1231.
21. Heyworth MF. Intestinal IgA responses to Giardia muris in mice depleted of helper T lymphocytes and in immunocompetent mice. J Parasitol 1989 75 : 246 251.
22. Leher H, Kinoshita K, Alizadeh H, Zaragoza FL, He Y Niederkorn J. Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection. Invest Ophthalmol Vis Sci 1998 39 : 2337 2343.
23. Petri WA Jr., Chaudhry O, Haque R Houpt E. Adherence-blocking vaccine for amebiasis. Arch Med Res 2006 37 : 288 291.
24. Kelsall BL Ravdin JI. Degradation of human IgA by Entamoeba histolytica. J Infect Dis 1993 168 : 1319 1322.
25. Tsutsumi V. In vivo experimental models of amebiasis. Gac Med Mex 1994 130 : 450 453.
26. Seydel KB, Li E, Swanson PE Stanley SL Jr. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect Immun 1997 65 : 1631 1639.
27. Ximenez C, Leyva O, Moran P et al. Entamoeba histolytica: antibody response to recent and past invasive events. Ann Trop Med Parasitol 1993 87 : 31 39.
28. Valenzuela O, Ramos F, Moran P et al. Persistence of secretory antiamoebic antibodies in patients with past invasive intestinal or hepatic amoebiasis. Parasitol Res 2001 87 : 849 852.
29. Calderon J, de Lourdes Munoz M Acosta HM. Surface redistribution and release of antibody-induced caps in entamoebae. J Exp Med 1980 151 : 184 193.
30. Del Muro R, Acosta E, Merino E, Glender W Ortiz-Ortiz L. Diagnosis of intestinal amebiasis using salivary IgA antibody detection. J Infect Dis 1990 162 : 1360 1364.
31. Haque R, Duggal P, Ali IM, et al. Innate and acquired resistance to amebiasis in Bangladeshi children. J Infect Dis 2002 186 : 547 552.
32. Ravdin JI, Abd-Alla MD, Welles SL, Reddy S Jackson TF. Intestinal antilectin immunoglobulin A antibody response and immunity to Entamoeba dispar infection following cure of amebic liver abscess. Infect Immun 2003 71 : 6899 6905.
33. Islam A, Stoll BJ, Ljungstrom I, Biswas J, Nazrul H Huldt G. The prevalence of Entamoeba histolytica in lactating women and in their infants in Bangladesh. Trans R Soc Trop Med Hyg 1988 82 : 99 103.
34. Carrero JC, Diaz MY, Viveros M et al. Human secretory immunoglobulin a anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells. Infect Immun 1994 62 : 764 767.
35. Guerrero-Manríquez GG, Sánchez-Ibarra F Ávila EE. Inhibition of Entamoeba histolytica proteolytic activity by human salivary IgA antibodies. APMIS 1998 106 : 1088 1094.
36. Houpt E, Barroso L, Lockhart L et al. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Vaccine 2004 22 : 611 617.
37. Zhang T Stanley SL Jr. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect Immun 1996 64 : 1526 1531.
38. Haque R, Mondal D, Kirkpatrick BD et al. Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entamoeba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh. Am J Trop Med Hyg 2003 69 : 398 405.
39. Haque R, Mondal D, Duggal P et al. Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infect Immun 2006 74 : 904 909.
40. Blessmann J, Ali IK, Nu PA et al. Longitudinal study of intestinal Entamoeba histolytica infections in asymptomatic adult carriers. J Clin Microbiol 2003 41 : 4745 4750.
41. Abd-Alla MD, Jackson TF, Rogers T, Reddy S Ravdin JI. Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response. Infect Immun 2006 74 : 3897 3903.
42. Ghosh PK, Mancilla R Ortiz-Ortiz L. Intestinal amebiasis: histopathologic features in experimentally infected mice. Arch Med Res 1994 25 : 297 302.
43. Houpt ER, Glembocki DJ, Obrig TG et al. The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. J Immunol 2002 169 : 4496 4503.
44. Tsutsumi V, Mena-Lopez R, Anaya-Velazquez F Martinez-Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol 1984 117 : 81 91.
45. Lotter H, Zhang T, Seydel KB, Stanley SL Jr. Tannich E. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis. J Exp Med 1997 185 : 1793 1801.
46. Ivory C, Kammanadiminti S Chadee K. Innate resistance to Entamoeba histolytica in murine models. Trends Parasitol 2007 23 : 46 48.
47. Corthesy B. Roundtrip ticket for secretory IgA: role in mucosal homeostasis? J Immunol 2007 178 : 27 32.
48. Hanna RM, Dahniya MH, Badr SS El-Betagy A. Percutaneous catheter drainage in drug-resistant amoebic liver abscess. Trop Med Int Health 2000 5 : 578 581.
49. Stanley SL Jr. Progress towards development of a vaccine for amebiasis. Clin Microbiol Rev 1997 10 : 637 649.
50. Petri WA Jr., Chaudhry O, Haque R Houpt E. Adherence-blocking vaccine for amebiasis. Arch Med Res 2006 37 : 288 291.
51. Lotter H Tannich E. The current status of an amebiasis vaccine. Arch Med Res 2006 37 : 292 296.
52. Choi MH, Sajed D, Poole L et al. An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack. Mol Biochem Parasitol 2005 143 : 80 89.
53. Carrero JC, Petrossian P, Acosta E, Sánchez-Zerpa M, Ortiz-Ortiz L Laclette JP. Cloning and characterization of Entamoeba histolytica antigens recognized by human secretory IgA antibodies. Parasitol Res 2000 86 : 330 334.
54. Singh M O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999 17 : 1075 1081.
55. Fooks AR. Development of oral vaccines for human use. Curr Opin Mol Ther 2000 2 : 80 86.
56. Thanavala Y, Huang Z Mason HS. Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Expert Rev Vaccines 2006 5 : 249 260.
57. Azad N Rojanasakul Y. Vaccine delivery - current trends and future. Curr Drug Deliv 2006 3 : 137 146.